Striated muscle activator of Rho signaling is required for myotube survival but does not influence basal protein synthesis or degradation

American Journal of Physiology - Cell Physiology

Volumn 305, Issue 4, 2013, Pages

  Wallace, Marita A ^a   Russell, Aaron P ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

Disuse; Exercise; Sarcomere; Skeletal muscle; STARS

Indexed keywords

CASPASE 2; ESTROGEN RELATED RECEPTOR ALPHA; INTERLEUKIN 1BETA CONVERTING ENZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE B; RHO FACTOR; S6 KINASE; STRIATED MUSCLE ACTIVATOR OF RHO SIGNALING PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; CELL DEATH; CELL REGENERATION; INFLAMMATION; MUSCLE CONTRACTION; MUSCLE GROWTH; MUSCLE METABOLISM; MYOTUBE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SKELETAL MUSCLE;

DISUSE; EXERCISE; SARCOMERE; SKELETAL MUSCLE; STARS;

ACTINS; ANIMALS; CELL LINE; CELL SURVIVAL; GENE EXPRESSION REGULATION; MICE; MICROFILAMENT PROTEINS; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MYOBLASTS, SKELETAL; PHOSPHORYLATION; POLYMERIZATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ESTROGEN; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA INTERFERENCE; RNA, MESSENGER; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSFECTION;

EID: 84881655302     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00421.2012     Document Type: Article

References (62)

1. Allen DL, Linderman JK, Roy RR, Bigbee AJ, Grindeland RE, Mukku V, Edgerton VR. Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. Am J Physiol Cell Physiol 273: C579-C587, 1997.
2. Arai A, Spencer JA, Olson EN. STARS, a striated muscle activator of Rho signaling and serum response factor-dependent transcription. J Biol Chem 277: 24453-24459, 2002.
3. Arany Z, Lebrasseur N, Morris C, Smith E, Yang W, Ma Y, Chin S, Spiegelman BM. The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab 5: 35-46, 2007.
4. Bassel-Duby R, Olson EN. Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 75: 19-37, 2006.
5. Burattini S, Ferri P, Battistelli M, Curci R, Luchetti F, Falcieri E. C2C12 murine myoblasts as a model of skeletal muscle development: morpho-functional characterization. Eur J Histochem 48: 223-233, 2004.
6. Charvet C, Houbron C, Parlakian A, Giordani J, Lahoute C, Bertrand A, Sotiropoulos A, Renou L, Schmitt A, Melki J, Li Z, Daegelen D, Tuil D. New role for serum response factor in postnatal skeletal muscle growth and regeneration via the interleukin 4 and insulin-like growth factor 1 pathways. Mol Cell Biol 26: 6664-6674, 2006.
7. Chong NW, Koekemoer AL, Ounzain S, Samani NJ, Shin JT, Shaw SY. STARS is essential to maintain cardiac development and function in vivo via a SRF pathway. PLos One 7: e40966, 2012.
8. Degens H, Alway SE. Control of muscle size during disuse, disease, and aging. Int J Sports Med 27: 94-99, 2006.
9. Denes A, Lopez-Castejon G, Brough D. Caspase-1: is IL-1 just the tip of the ICEberg? Cell Death Dis 3: e338, 2012.
10. Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18: 7719-7730, 1999.
11. Fluck M. Functional, structural and molecular plasticity of mammalian skeletal muscle in response to exercise stimuli. J Exp Biol 209: 2239-2248, 2006.
12. Garnier A, Fortin D, Delomenie C, Momken I, Veksler V, Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 551: 491-501, 2003.
13. Giger JM, Bodell PW, Zeng M, Baldwin KM, Haddad F. Rapid muscle atrophy response to unloading: pretranslational processes involving MHC and actin. J Appl Physiol 107: 1204-1212, 2009.
14. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 37: 1974-1984, 2005.
15. Goodman CA, Mayhew DL, Hornberger TA. Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass. Cell Signal 23: 1896-1906, 2011.
16. Greenbaum D, Colangelo C, Williams K, Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4: 117, 2003.
17. Handschin C, Chin S, Li P, Liu F, Maratos-Flier E, Lebrasseur NK, Yan Z, Spiegelman BM. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals. J Biol Chem 282: 30014-30021, 2007.
18. Hupkes M, Jonsson MK, Scheenen WJ, van Rotterdam W, Sotoca AM, van Someren EP, van der Heyden MA, van Veen TA, van Ravestein-van Os RI, Bauerschmidt S, Piek E, Ypey DL, van Zoelen EJ, Dechering KJ. Epigenetics: DNA demethylation promotes skeletal myotube maturation. FASEB J 25: 3861-3872, 2011.
19. Jensen GL. Inflammation: roles in aging and sarcopenia. JPEN J Parenter Enteral Nutr 32: 656-659, 2008.
20. Kleiner S, Nguyen-Tran V, Bare O, Huang X, Spiegelman B, Wu Z. PPAR agonism activates fatty acid oxidation via PGC-1α but does not increase mitochondrial gene expression and function. J Biol Chem 284: 18624-18633, 2009.
21. Knutti D, Kralli A. PGC-1, a versatile coactivator. Trends Endocrinol Metab 12: 360-365, 2001.
22. Koekemoer AL, Chong NW, Goodall AH, Samani NJ. Myocyte stress 1 plays an important role in cellular hypertrophy and protection against apoptosis. FEBS Lett 583: 2964-2967, 2009.
23. Kumar V, Atherton P, Smith K, Rennie MJ. Human muscle protein synthesis and breakdown during and after exercise. J Appl Physiol 106: 2026-2039, 2009.
24. Kuwahara K, Barrientos T, Pipes GC, Li S, Olson EN. Muscle-specific signaling mechanism that links actin dynamics to serum response factor. Mol Cell Biol 25: 3173-3181, 2005.
25. Kuwahara K, Pipes GC, McAnally J, Richardson JA, Hill JA, Bassel-Duby R, Olson EN. Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity. J Clin Invest 117: 1324-1334, 2007.
26. Lamon S, Wallace MA, Leger B, Russell AP. Regulation of STARS and its downstream targets suggest a novel pathway involved in human skeletal muscle hypertrophy and atrophy. J Physiol 587: 1795-1803, 2009.
27. Leeuwenburgh C. Role of apoptosis in sarcopenia. J Gerontol A Biol Sci Med Sci 58: 999-1001, 2003.
28. Lek M, North KN. Are biological sensors modulated by their structural scaffolds? The role of the structural muscle proteins α-actinin-2 and α-actinin-3 as modulators of biological sensors. FEBS Lett 584: 2974-2980, 2010.
29. Lynch GS, Faulkner JA, Brooks SV. Force deficits and breakage rates after single lengthening contractions of single fast fibers from unconditioned and conditioned muscles of young and old rats. Am J Physiol Cell Physiol 295: C249-C256, 2008.
30. MacDougall JD, Gibala MJ, Tarnopolsky MA, MacDonald JR, Interisano SA, Yarasheski KE. The time course for elevated muscle protein synthesis following heavy resistance exercise. Can J Appl Physiol 20: 480-486, 1995.
31. Mahadeva H, Brooks G, Lodwick D, Chong NW, Samani NJ. ms1, a novel stress-responsive, muscle-specific gene that is up-regulated in the early stages of pressure overload-induced left ventricular hypertrophy. FEBS Lett 521: 100-104, 2002.
32. Menconi M, Gonnella P, Petkova V, Lecker S, Hasselgren PO. Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes. J Cell Biochem 105: 353-364, 2008.
33. Miano JM, Long X, Fujiwara K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 292: C70-C81, 2007.
34. Moore ML, Park EA, McMillin JB. Upstream stimulatory factor represses the induction of carnitine palmitoyltransferase-Iβ expression by PGC-1. J Biol Chem 278: 17263-17268, 2003.
35. Moore ML, Wang GL, Belaguli NS, Schwartz RJ, McMillin JB. GATA-4 and serum response factor regulate transcription of the musclespecific carnitine palmitoyltransferase Iβ in rat heart. J Biol Chem 276: 1026-1033, 2001.
36. Morel E, Parton RG, Gruenberg J. Annexin A2-dependent polymerization of actin mediates endosome biogenesis. Dev Cell 16: 445-457, 2009.
37. Motani K, Kushiyama H, Imamura R, Kinoshita T, Nishiuchi T, Suda T. Caspase-1 protein induces apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC)-mediated necrosis independently of its catalytic activity. J Biol Chem 286: 33963-33972, 2011.
38. Paoni NF, Peale F, Wang F, Errett-Baroncini C, Steinmetz H, Toy K, Bai W, Williams PM, Bunting S, Gerritsen ME, Powell-Braxton L. Time course of skeletal muscle repair and gene expression following acute hind limb ischemia in mice. Physiol Genomics 11: 263-272, 2002.
39. Peng YB, Guan HP, Fan B, Zhao SH, Xu XW, Li K, Zhu MJ, Yerle M, Liu B. Molecular characterization and expression pattern of the porcine STARS, a striated muscle-specific expressed gene. Biochem Genet 46: 644-651, 2008.
40. Pette D, Staron RS. Myosin isoforms, muscle fiber types, and transitions. Microsc Res Tech 50: 500-509, 2000.
41. Plaisance I, Morandi C, Murigande C, Brink M. TNF-α increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK. Am J Physiol Endocrinol Metab 294: E241-E250, 2008.
42. Pollanen E, Fey V, Tormakangas T, Ronkainen PH, Taaffe DR, Takala T, Koskinen S, Cheng S, Puolakka J, Kujala UM, Suominen H, Sipila S, Kovanen V. Power training and postmenopausal hormone therapy affect transcriptional control of specific co-regulated gene clusters in skeletal muscle. Age 32: 347-363, 2010.
43. Rangwala SM, Wang X, Calvo JA, Lindsley L, Zhang Y, Deyneko G, Beaulieu V, Gao J, Turner G, Markovits J. Estrogen-related receptor-γ is a key regulator of muscle mitochondrial activity and oxidative capacity. J Biol Chem 285: 22619-22629, 2010.
44. Rawat R, Cohen TV, Ampong B, Francia D, Henriques-Pons A, Hoffman EP, Nagaraju K. Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle. Am J Pathol 176: 2891-2900, 2010.
45. Russell AP. Molecular regulation of skeletal muscle mass. Clin Exp Pharmacol Physiol 37: 378-384, 2010.
46. Sakuma K, Akiho M, Nakashima H, Akima H, Yasuhara M. Agerelated reductions in expression of serum response factor and myocardinrelated transcription factor A in mouse skeletal muscles. Biochim Biophys Acta 1782: 453-461, 2008.
47. Sakuma K, Watanabe K, Hotta N, Koike T, Ishida K, Katayama K, Akima H. The adaptive responses in several mediators linked with hypertrophy and atrophy of skeletal muscle after lower limb unloading in humans. Acta Physiol (Oxf) 197: 151-159, 2009.
48. Schreiber SN, Emter R, Hock MB, Knutti D, Cardenas J, Podvinec M, Oakeley EJ, Kralli A. The estrogen-related receptor-α (ERRα) functions in PPARγ coactivator 1α (PGC-1α)-induced mitochondrial biogenesis. Proc Natl Acad Sci USA 101: 6472-6477, 2004.
49. Shen WH, Boyle DW, Wisniowski P, Bade A, Liechty EA. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids. J Endocrinol 185: 275-289, 2005.
50. Shireman PK, Contreras-Shannon V, Ochoa O, Karia BP, Michalek JE, McManus LM. MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration. J Leukoc Biol 81: 775-785, 2007.
51. Small EM, O'Rourke JR, Moresi V, Sutherland LB, McAnally J, Gerard RD, Richardson JA, Olson EN. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci USA 107: 4218-4223, 2010.
52. Spangenburg EE. SOCS-3 induces myoblast differentiation. J Biol Chem 280: 10749-10758, 2005.
53. Srere PA. Citrate synthase: [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoAacetylating)]. In: Methods in Enzymology, edited by Lowenstein JM. New York: Academic, 1969, p. 3-11.
54. Talmadge RJ. Myosin heavy chain isoform expression following reduced neuromuscular activity: potential regulatory mechanisms. Muscle Nerve 23: 661-679, 2000.
55. Thomason DB, Booth FW. Atrophy of the soleus muscle by hindlimb unweighting. J Appl Physiol 68: 1-12, 1990.
56. Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 288: R345-R353, 2005.
57. Toth KG, McKay BR, De Lisio M, Little JP, Tarnopolsky MA, Parise G. IL-6 induced STAT3 signalling is associated with the proliferation of human muscle satellite cells following acute muscle damage. PLos One 6: e17392, 2011.
58. Troidl K, Ruding I, Cai WJ, Mucke Y, Grossekettler L, Piotrowska I, Apfelbeck H, Schierling W, Volger OL, Horrevoets AJ, Grote K, Schmitz-Rixen T, Schaper W, Troidl C. Actin-binding Rho activating protein (Abra) is essential for fluid shear stress-induced arteriogenesis. Arterioscler Thromb Vasc Biol 29: 2093-2101, 2009.
59. Vandenburgh HH, Hatfaludy S, Karlisch P, Shansky J. Skeletal muscle growth is stimulated by intermittent stretch-relaxation in tissue culture. Am J Physiol Cell Physiol 256: C674-C682, 1989.
60. Wallace MA, Hock MB, Hazen BC, Kralli A, Snow RJ, Russell AP. Striated muscle activator of Rho signalling (STARS) is a PGC-1α/ oestrogen-related receptor-α target gene and is upregulated in human skeletal muscle after endurance exercise. J Physiol 589: 2027-2039, 2011.
61. Yarasheski KE, Zachwieja JJ, Bier DM. Acute effects of resistance exercise on muscle protein synthesis rate in young and elderly men and women. Am J Physiol Endocrinol Metab 265: E210-E214, 1993.
62. Yndestad A, Damas JK, Oie E, Ueland T, Gullestad L, Aukrust P. Systemic inflammation in heart failure-the whys and wherefores. Heart Fail Rev 11: 83-92, 2006.